Prior Authorization Drug List
|
|
- Erick Shelton
- 5 years ago
- Views:
Transcription
1 Prior Authorization Drug List This is a list of drugs that require Prior Authorization before coverage is provided. If you are prescribed a medication that requires Prior Authorization, your physician will need to contact PreferredOne at the number provided on your ID card to request a prior authorization review. PreferredOne will review the request to determine if the medication use is consistent with your benefit coverage and will notify you and your physician of the coverage determination. Without prior authorization approval, these drugs may not be covered by your pharmacy benefit. This list is subject to change throughout the year. The presence of a drug on this list does not guarantee coverage and not all drugs included on this list may be covered by your pharmacy benefit plan. Coverage of medications is determined your benefit plan. Your plan may require prior authorization for additional medications not included on this list. Drug Class ANALGESICS ABSTRAL acetaminophen-codeine ARYMO ER aspirin-caffeine-dihydrocodein buprenorphine butalb-caff-acetaminoph-codein butorphanol tartrate carisoprodol compound-codeine codeine sulfate DEMEROL DOLOPHINE HCL EMBEDA EXALGO fentanyl citrate acetamin-caff-dihydrocodeine ACTIQ ascomp with codeine BELBUCA butalb-acetaminoph-caff-codein butalbital compound-codeine BUTRANS carisoprodol-aspirin-codeine CONZIP DILAUDID DURAGESIC endocet fentanyl FENTORA FIORICET WITH CODEINE FIORINAL WITH CODEINE #3 HYCET hydrocodone-ibuprofen hydromorphone hcl ibudone hydrocodone-acetaminophen hydromorphone er HYSINGLA ER KADIAN
2 ANALGESICS -- Continued LAZANDA lorcet hd lortab methadone hcl morphine sulfate er NORCO NUCYNTA ER lorcet lorcet plus meperidine hcl morphine sulfate MS CONTIN NUCYNTA OPANA OPANA ER oxycodone hcl oxycodone hcl-aspirin oxycodone-acetaminophen oxymorphone hcl pentazocine-naloxone hcl primlev ROXICODONE SUBSYS tramadol hcl tramadol hcl-acetaminophen TYLENOL-CODEINE NO.3 OXAYDO oxycodone hcl er oxycodone hcl-ibuprofen OXYCONTIN oxymorphone hcl er PERCOCET REPREXAIN ROXYBOND SYNALGOS-DC tramadol hcl er TREZIX TYLENOL-CODEINE NO.4 ULTRACET ULTRAM verdrocet vicodin vicodin es vicodin hp XODOL XODOL ANTIBACTERIALS ANTICONVULSANTS XODOL xylon 10 ZOHYDRO ER ARIKAYCE clobazam ONFI vigabatrin XTAMPZA ER ZAMICET XIFAXAN EPIDIOLEX SABRIL vigadrone
3 ANTIEMETICS ANTIFUNGALS ANTIMIGRAINE AGENTS ANTINEOPLASTICS dronabinol SYNDROS itraconazole SPORANOX AIMOVIG AUTOINJECTOR AJOVY AFINITOR ALECENSA bexarotene BRAFTOVI CALQUENCE CAPRELSA COPIKTRA ERIVEDGE FARYDAK GLEEVEC ICLUSIG imatinib mesylate INLYTA JAKAFI KISQALI FEMARA CO-PACK LONSURF LYNPARZA MEKTOVI NEXAVAR ODOMZO REVLIMID RUBRACA SPRYCEL SUTENT SYNRIBO MARINOL ONMEL AIMOVIG AUTOINJECTOR (2 PACK) EMGALITY AFINITOR DISPERZ ALUNBRIG BOSULIF CABOMETYX capecitabine COMETRIQ COTELLIC ERLEADA GILOTRIF IBRANCE IDHIFA IMBRUVICA IRESSA KISQALI LENVIMA LORBRENA MEKINIST NERLYNX NINLARO POMALYST RITUXAN HYCELA RYDAPT STIVARGA SYLATRON TAFINLAR
4 ANTINEOPLASTICS -- Continued TAGRISSO TARCEVA TEMODAR THALOMID TYKERB VELCADE VENCLEXTA STARTING PACK VIZIMPRO XALKORI XTANDI ZEJULA ZOLINZA ZYKADIA TALZENNA TASIGNA temozolomide TIBSOVO VALCHLOR VENCLEXTA VERZENIO VOTRIENT XELODA YONSA ZELBORAF ZYDELIG ZYTIGA ANTIPARASITICS ANTIPARKINSON AGENTS ANTIPSYCHOTICS ANTIVIRALS albendazole DARAPRIM quinine sulfate APOKYN ADASUVE DAKLINZA HARVONI MAVYRET PEGASYS PEGINTRON PREVYMIS SOVALDI VIEKIRA PAK VOSEVI ALBENZA QUALAQUIN DUOPA NUPLAZID EPCLUSA INTRON A OLYSIO PEGASYS PROCLICK PEGINTRON REDIPEN SELZENTRY TECHNIVIE VIEKIRA XR ZEPATIER
5 BLOOD GLUCOSE REGULATORS Drug Class BLOOD GLUCOSE REGULATORS -- Continued AFREZZA chlorpropamide SYMLINPEN 120 SYMLINPEN 60 BLOOD PRODUCTS/MODIFIERS/VOLUME EXPANDERS ARANESP FULPHILA LEUKINE MOZOBIL NEULASTA NIVESTYM PROCRIT RETACRIT EPOGEN GRANIX MIRCERA MULPLETA NEUPOGEN NPLATE PROMACTA TAVALISSE CARDIOVASCULAR AGENTS ZARXIO CORLANOR KEVEYIS NORTHERA PRALUENT SYRINGE REPATHA SURECLICK simvastatin JUXTAPID KYNAMRO PRALUENT PEN REPATHA PUSHTRONEX REPATHA SYRINGE ZOCOR CENTRAL NERVOUS SYSTEM AGENTS ADDERALL ADZENYS ER amphetamine sulfate APTENSIO XR AUSTEDO AVONEX PEN CONCERTA COTEMPLA XR-ODT DAYTRANA DEXEDRINE dexmethylphenidate hcl er dextroamphetamine sulfate er dextroamphetamine-amphetamine ADDERALL XR ADZENYS XR-ODT AMPYRA AUBAGIO AVONEX BETASERON COPAXONE dalfampridine er DESOXYN dexmethylphenidate hcl dextroamphetamine sulfate dextroamphetamine-amphet er DYANAVEL XR
6 CENTRAL NERVOUS SYSTEM AGENTS -- Continued EVEKEO FOCALIN GILENYA glatopa INGREZZA metadate er METHYLIN methylphenidate er (la) methylphenidate hcl cd methylphenidate la NUEDEXTA PLEGRIDY PEN QUILLICHEW ER REBIF RILUTEK RITALIN TECFIDERA TIGLUTIK XENAZINE zenzedi ZINBRYTA EXTAVIA FOCALIN XR glatiramer acetate HORIZANT METADATE CD methamphetamine hcl methylphenidate er methylphenidate hcl methylphenidate hcl er (cd) MYDAYIS PLEGRIDY procentra QUILLIVANT XR REBIF REBIDOSE riluzole RITALIN LA tetrabenazine VYVANSE ZENZEDI ZENZEDI DERMATOLOGICAL AGENTS ABSORICA amnesteem AVITA COSENTYX (2 SYRINGES) COSENTYX PEN (2 PENS) DUPIXENT myorisan RETIN-A RETIN-A MICRO PUMP TALTZ AUTOINJECTOR TALTZ AUTOINJECTOR (3 PACK) adapalene ATRALIN claravis COSENTYX PEN COSENTYX SYRINGE isotretinoin REGRANEX RETIN-A MICRO STELARA TALTZ AUTOINJECTOR (2 PACK) TALTZ SYRINGE
7 DERMATOLOGICAL AGENTS -- Continued tretinoin zenatane ENZYME REPLACEMENT/MODIFIERS TALTZ SYRINGE (2 PACK) TREMFYA BRINEURA GALAFOLD miglustat ORFADIN PROCYSBI STRENSIQ TALTZ SYRINGE (3 PACK) TRETIN-X tretinoin microsphere CERDELGA KUVAN NITYR PALYNZIQ RAVICTI ZAVESCA GASTROINTESTINAL AGENTS GENITOURINARY AGENTS alosetron hcl GATTEX OCALIVA VIBERZI XERMELO CUPRIMINE CHOLBAM LOTRONEX RELISTOR XENICAL HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (ADRENAL) EMFLAZA KORLYM HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (PITUITARY) chorionic gonadotropin HUMATROPE GENOTROPIN INCRELEX NORDITROPIN FLEXPRO NUTROPIN AQ OMNITROPE SAIZEN SEROSTIM NOVAREL NUTROPIN AQ NUSPIN PREGNYL SAIZEN-SAIZENPREP ZOMACTON ZORBTIVE HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (SEX HORMONES/MODIFIERS) ANADROL-50 ANDRODERM ANDROGEL AVEED androxy AXIRON
8 HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING (SEX HORMONES/MODIFIERS) -- Continued DEPO-TESTOSTERONE FORTESTA hydroxyprogesterone caproate METHITEST NATESTO oxandrolone testosterone testosterone enanthate XYOSTED HORMONAL AGENTS, SUPPRESSANT (PARATHYROID) SENSIPAR MAKENA methyltestosterone OXANDRIN TESTIM testosterone cypionate VOGELXO HORMONAL AGENTS, SUPPRESSANT (PITUITARY) EGRIFTA FIRMAGON LUPANETA PACK LUPRON DEPOT-PED SANDOSTATIN SIGNIFOR SOMATULINE DEPOT SUPPRELIN LA TRIPTODUR ELIGARD leuprolide acetate LUPRON DEPOT octreotide acetate SANDOSTATIN LAR DEPOT SIGNIFOR LAR SOMAVERT TRELSTAR VANTAS IMMUNOLOGICAL AGENTS ACTEMRA BENLYSTA CUVITRU ENBREL MINI FIRAZYR GAMASTAN S-D GAMMAKED HAEGARDA HUMIRA HUMIRA PEN HUMIRA PEN PSORIASIS-UVEITIS ILARIS KALBITOR ARCALYST CIMZIA ENBREL ENBREL SURECLICK GAMASTAN GAMMAGARD LIQUID GAMUNEX-C HIZENTRA HUMIRA PEDIATRIC CROHN'S HUMIRA PEN CROHN-UC-HS STARTER HYQVIA ILUMYA KEVZARA
9 IMMUNOLOGICAL AGENTS -- Continued METABOLIC BONE DISEASE AGENTS KINERET ORENCIA OTEZLA RASUVO SIMPONI ARIA SYNAGIS VARIZIG XELJANZ XR FORTEO PROLIA OLUMIANT ORENCIA CLICKJECT OTREXUP SIMPONI STELARA TAKHZYRO XELJANZ ZORTRESS NATPARA TYMLOS XGEVA MISCELLANEOUS THERAPEUTIC AGENTS ADDYI BELVIQ benzphetamine hcl CETROTIDE diethylpropion hcl er EUFLEXXA GANIRELIX ACETATE adipex-p BELVIQ XR BRAVELLE diethylpropion hcl DUROLANE FOLLISTIM AQ gel-one GELSYN-3 genvisc 850 GONAL-F GONAL-F RFF REDI-JECT hydrocod-cpm-pseudoephedrine hydrocodone-homatropine mbr HYMOVIS MENOPUR MYALEPT NUCALA ORILISSA phendimetrazine tartrate phentermine hcl promethazine-codeine REGIMEX GONAL-F RFF HYALGAN hydrocodone-chlorpheniramne er hydromet lomaira MONOVISC MYOBLOC ODACTRA ORTHOVISC phendimetrazine tartrate er promethazine vc-codeine promethazine-phenyleph-codeine REZIRA
10 MISCELLANEOUS THERAPEUTIC AGENTS -- Continued SAXENDA SYNVISC TEGSEDI trivisc TUSSIONEX visco-3 XIAFLEX supartz fx SYNVISC-ONE THYROGEN tussigon TUZISTRA XR VITUZ XURIDEN OPHTHALMIC AGENTS ZUTRIPRO CYSTARAN RESTASIS XIIDRA LUXTURNA RESTASIS MULTIDOSE RESPIRATORY TRACT/PULMONARY AGENTS ADCIRCA CAYSTON ESBRIET GRASTEK LETAIRIS OPSUMIT ORENITRAM ER PULMOZYME REMODULIN sildenafil tadalafil 20 mg tablet (generic for adcirca) TYVASO TYVASO REFILL KIT UPTRAVI ADEMPAS DALIRESP FASENRA KALYDECO OFEV ORALAIR ORKAMBI RAGWITEK REVATIO SYMDEKO TRACLEER TYVASO INSTITUTIONAL START KIT TYVASO STARTER KIT VENTAVIS XOLAIR SKELETAL MUSCLE RELAXANTS BOTOX DYSPORT SLEEP DISORDER AGENTS XEOMIN armodafinil HETLIOZ flurazepam hcl modafinil
11 SLEEP DISORDER AGENTS -- Continued NUVIGIL THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES EXJADE JADENU PROVIGIL FERRIPROX JADENU SPRINKLE
12 PreferredOne Insurance Company Nondiscrimination Notice PreferredOne Insurance Company ( PIC ) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. PIC does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. PIC: Provides free aids and services to people with disabilities to communicate effectively with us, such as: Qualified sign language interpreters Written information in other formats (large print, audio, accessible electronic formats, other formats) Provides free language services to people whose primary language is not English, such as: Qualified interpreters Information written in other languages If you need these services, contact a Grievance Specialist. If you believe that PIC has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Grievance Specialist PreferredOne Insurance Company PO Box Minneapolis, MN Phone: (TTY: ) Fax: customerservice@preferredone.com You can file a grievance in person or by mail, fax, or . If you need help filing a grievance, a Grievance Specialist is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C , (TDD) Complaint forms are available at NDR PIC LV (1/18)
13 PreferredOne Community Health Plan Nondiscrimination Notice PreferredOne Community Health Plan ( PCHP ) complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. PCHP does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. PCHP: Provides free aids and services to people with disabilities to communicate effectively with us, such as: Qualified sign language interpreters Written information in other formats (large print, audio, accessible electronic formats, other formats) Provides free language services to people whose primary language is not English, such as: Qualified interpreters Information written in other languages If you need these services, contact a Grievance Specialist. If you believe that PCHP has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Grievance Specialist PreferredOne Community Health Plan PO Box Minneapolis, MN Phone: (TTY: ) Fax: customerservice@preferredone.com You can file a grievance in person or by mail, fax, or . If you need help filing a grievance, a Grievance Specialist is available to help you. You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at or by mail or phone at: U.S. Department of Health and Human Services 200 Independence Avenue, SW Room 509F, HHH Building Washington, D.C , (TDD) Complaint forms are available at NDR PCHP LV (1/18)
Prior Authorization Drug List
Prior Authorization Drug List This is a list of drugs that require Prior Authorization before coverage is provided. If you are prescribed a medication that requires Prior Authorization, your physician
More informationSpecialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs
Specialty Drugs The following is a list of medications that are considered to be specialty drugs. Specialty drugs include self-administered injectables, medications that are high cost, and/or medications
More informationSpecialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.
Specialty Drugs The following is a list of medications that are considered specialty drugs. Specialty drugs include self-administered injectables, medications that are high cost, and/or medications that
More informationMETABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST
PRIOR AUTHORIZATION LIST (SUBJECT TO CHANGE) MEDICATION THERAPEUTIC CATEGORY MODULE ACTEMRA INFLAMMATORY CONDITIONS ACTEMRA ADCIRCA PULMONARY HYPERTENSION PDE-5 INHIBITORS FOR PAH ADDYI SEXUAL DISORDERS
More informationDRUGS REQUIRING PRIOR AUTHORIZATION
DRUGS REQUIRING PRIOR AUTHORIZATION Medication Abstral Actemra Acthar Gel Actiq* Adcirca Adderall Adderall XR Addyi Adempas Adipex* Adzenys XR-ODT Afinitor Afinitor Alecensa Alecensa Ampyra Androderm AndroGel
More informationPulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.
Prior Authorization PricewaterhouseCoopers The following medications may require prior authorization prior to dispensing at a participating retail pharmacy or through the Express Scripts Pharmacy home
More information2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018
Abstral Actemra Adcirca Adempas Aliqopa Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio
More information2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017
Abstral Actemra Adcirca Adempas Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio Beleodaq
More informationacromegaly Drugs Covered Uses Exclusion Criteria Required Medical Information Age Restriction Prescriber Restriction Coverage Duration
acromegaly SIGNIFOR, SOMATULINE DEPOT SUBCUTANEOUS SYRINGE 120 MG/0.5 ML, 60 MG/0.2 ML, 90 MG/0.3 ML, SOMAVERT SUBCUTANEOUS RECON SOLN 15 MG, 20 MG, 25 MG, 30 MG All medically accepted indications not
More informationPrior Authorization Program Information (Effective April 1st, 2018)
Prior Authorization Program Information (Effective April 1st, 2018) Prior Authorization Certain drugs require prior authorization to help promote safe, quality and affordable pharmacy care. Your doctor
More informationLista de medicamentos especializados
Lista de medicamentos especializados Vigencia: 1o. de enero de 2016 A continuación se listan, en orden alfabético, los medicamentos de especialidad recetados más frecuentemente. Los medicamentos de especialidad
More informationafter reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related
Store at room temp. Protect from bright light. Freezing or refrigerating do not adversely affect the stability of intact vials. Different standards apply Abraxane Oncology- Injectable IV No No Yes after
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Controlled Substance Analgesic and Narcotic Antagonist Quantity Limitations Table of Contents Coverage Policy... 1 General Background... 6 Coding/Billing
More informationAetna Better Health. Specialty Drug Program
Aetna Better Health is managed through CVS Health Specialty Pharmacy. The Specialty pharmacies fill prescriptions and ship drugs for complex medical conditions, including multiple sclerosis, rheumatoid
More informationALPHA1-PROTEINASE INHIBITOR
Ally Rx D-SNP Current as of Nov. 1, 2018 ALPHA1-PROTEINASE INHIBITOR ARALAST NP INTRAVENOUS RECON SOLN 1,000 MG GLASSIA PROLASTIN-C INTRAVENOUS RECON SOLN ZEMAIRA PA Documentation of diagnosis, lab results,
More informationSpecialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer
ANTI-INFECTIVE ABELCET 100 MG/20 ML VIAL 4/1/2017 ANTI-INFECTIVE AMBISOME 50 MG VIAL 4/1/2017 ANTI-INFECTIVE ANCOBON 250 MG CAPSULE 4/1/2017 ANTI-INFECTIVE ANCOBON 500 MG CAPSULE 4/1/2017 ANTI-INFECTIVE
More informationPrior Authorization Drug List
Prior Authorization Drug List Drug Class 5-HT3 RECEPTOR ANTAGONISTS AKYNZEO ADRENALS EMFLAZA ADRENOCORTICAL INSUFFICIENCY H.P. ACTHAR ALPHA AND BETA ADRENERGIC AGONIST(RESPR) ADRENACLICK EPIPEN AUVI-Q
More informationCapital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)
Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have
More informationPRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION
Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate
More informationTrusted Health Plan Formulary
2018 Trusted Health Plan Formulary Version 19; Effective 10/22/18 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria...
More informationPRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION
Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate
More informationOpiate/Benzodiazepine/Muscle Relaxant Combinations
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Opiate/Benzodiazepine/Muscle Relaxant Combinations Clinical Edit Information Included in this Document Drugs requiring prior authorization:
More informationAlly Rx D-SNP Current as of r 1, 2017
Ally Rx D-SNP Current as of r 1, 2017 AMPYRA AMPYRA PA Moderate to severe renal impairment (CrCL less than or equal to 50ml/min), patient not able to walk 25 feet in 8-45 seconds. Documentation of diagnosis,
More informationLIMITED DISTRIBUTION MEDICATIONS
ACTEMRA IV (USSC can dispense 162 mg PFS) ACTHAR HP ACTIMMUNE ADAGEN ADCETRIS CVS Specialty 1-800-237-2767 1-800-237-2767 ADEMPAS ADVATE ALDURAZYME ALECENSA ALIQOPA ALUNBRIG AMPYRA APOKYN ARALAST NP ARCALYST
More informationGeneric Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE
STATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE 3 Great Circle Road NASHVILLE, TENNESSEE 37243 This notice is to advise
More informationSELF-ADMINISTERED MEDICATIONS LIST
SELF-ADMINISTERED MEDICATIONS LIST Table of Contents Page Last Updated: January 23, 2019 INSTRUCTIONS FOR USE... 1 APPLICABLE CODES... 1 Related Commercial Policy LIST HISTORY/REVISION INFORMATION... 5
More informationPRESCRIPTION DRUG LIST CHANGES
PRESCRIPTION DRUG LIST CHANGES Cigna Pharmacy Management The medications listed below are changing coverage (or cost levels) on Cigna s Prescription Drug List. Changes are listed by drug list and by the
More informationXyrem (Sodium Oxybate)
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationList of Designated High-Cost Drugs
List of Designated High-Cost Drugs UPDATED APRIL 25, 2018 For details on the High-Cost Drug policy, see Section 5.8 of the PharmaCare Policy Manual. Recent updates appear in red. Deletions are listed at
More informationExclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or
Noridian Healthcare Solutions, LLC Jurisdiction F Part B Self-Administered Drug (SAD) Exclusion List (A53033); Effective 8/7/2017 The following medications are considered self-administered and are not
More informationCHANGES TO YOUR DRUG LIST
CHANGES TO YOUR DRUG LIST More generics and lower-cost brands to help you stay healthy and save money At Cigna, it s our goal to offer you access to coverage for safe, effective and affordable medications.
More informationTrusted Health Plan Formulary
2018 Trusted Health Plan Formulary Effective 7/1/2018 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria... 6 Formulary
More informationCovered Uses All medically accepted indications not otherwise excluded from Part D.
AAT DEFICIENCY Aralast NP intravenous recon soln 1,000 mg Glassia Prolastin-C intravenous recon soln Zemaira PA Details Age Other Diagnosis of severe congenital A1-PI deficiency who have clinically evident
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of drugs by drug class
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More information2019 Prior Authorization
2019 Prior Authorization FID 19148 Prior Authorization ACTEMRA Products Affected Actemra INJ 162MG/0.9ML PA Details Age Other 1 ACTIMMUNE Products Affected Actimmune PA Details Age Other 2 ADEMPAS Products
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 7/1/2017, Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of
More informationADCIRCA. Products Affected Adcirca. Prior Authorization Criteria 2017 MMP Effective Date: 11/01/2017 Approval Date: 11/01/2017
Prior Authorization 2017 MMP Effective Date: 11/01/2017 Approval Date: 11/01/2017 ADCIRCA Products Affected Adcirca PA Details All FDA-approved indications not otherwise Other Patients taking nitrates
More information2019 Prior Authorization
2019 Prior Authorization FID 19148 Prior Authorization ACTEMRA Products Affected Actemra INJ 162MG/0.9ML Actemra Actpen Other 1 ACTIMMUNE Products Affected Actimmune Other 2 ADEMPAS Products Affected Adempas
More informationOpioid Management Program May 2018
Opioid Management Program May 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of daily
More informationNew Hampshire Healthy Families CLINICAL POLICY
New Hampshire Healthy Families CLINICAL POLICY DEPARTMENT: Pharmacy DOCUMENT NAME: Opioid Analgesics PAGE: 1 o f 6 REFERENCE NUMBER: NH.PPA.13 EFFECTIVE DATE: 6/1/2016 REPLACES DOCUMENT: N/A RETIRED: REVIEWED:
More informationDiagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema, weight, A1-PI phenotype, A1-PI baseline level
AAT DEFICIENCY Aralast NP intravenous recon soln 1,000 Prolastin-C intravenous recon soln mg Zemaira Glassia Other Diagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema,
More informationPrescription Drug Benefit Rider V
Prescription Drug Benefit Rider V Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your
More informationPrescription Drug Benefit Rider
Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your
More informationDiagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema, weight, A1-PI phenotype, A1-PI baseline level
AAT DEFICIENCY Aralast NP intravenous recon soln 1,000 mg Glassia Prolastin-C intravenous recon soln Zemaira Other Diagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema,
More informationOpioid Management Program October 2018
Opioid Management Program October 2018 What Is the Opioid Management Program? This program is based on guidelines developed by the U.S. Centers for Disease Control and Prevention (CDC). It consists of
More information** Fee-For-Service Pharmacy Provider Notice #229 May 2018 PDL Changes **
** Fee-For-Service Pharmacy Provider Notice #229 May 2018 PDL Changes ** August 03, 2018 Please be advised that the Department for Medicaid Services (DMS) is making changes to the Kentucky Medicaid Fee-For-Service
More informationBuckeye Health Plan (MMP) 2016 Prior Authorization Criteria
Buckeye Health Plan (MMP) 2016 Prior Authorization Instructions: 1. With this file, at the top, click Edit, then click Find. 2. In the Find box type the name of the medication you want to find. 3. Click
More informationOpioid Analgesic/Opioid Combination Products
Market DC Opioid Analgesic/Opioid Combination Products Override(s) Quantity Limit Approval Duration 1 year Generic Name Brand Name Quantity Limit APAP/Caf/Dihydrocodeine 320.5mg/30mg/16mg APAP/Caf/Dihydrocodeine
More informationFuture Formulary Changes
Future Formulary Changes Upd 09/11/2018 Applies to: Employer group plan 2018 open formularies KEY: =prior authorization; ST=step therapy; QL=quantity limit Generic name Brand name Change Effective Hydroxyprogesterone
More informationOpioid Analgesic/Opioid Combination Products
Opioid Analgesic/Opioid Combination Products Override(s) Quantity Limit Approval Duration 1 year Generic Name Brand Name Quantity Limit 320.5mg/30mg/16mg 356.4mg/30mg/16mg 325mg/30mg/16mg Trezix (new formulation)
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Opioid Immediate Release Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Opioid Immediate Release Prime Therapeutics will review Prior Authorization
More informationPharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS
Workforce Safety & Insurance Revised Document Date: 07/23/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management
More informationAPPROVED PA CRITERIA. Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION
Initial Approval: January 10, 2018 Revised Dates: April 11, 2018 CRITERIA FOR PRIOR AUTHORIZATION PROVIDER GROUP Pharmacy Opioid Products Indicated for Pain Management MANUAL GUIDELINES All dosage forms
More informationACITRETIN. Products Affected
ACITRETIN acitretin Other For prophylaxis of skin cancer in patients with previously treated skin cancers who have undergone an organ transplantation the request will be approved. For psoriasis: the patient
More informationCENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description
CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY Coverage Guideline Policy & Procedure HIM.PA.32 Long acting stimulants (Adderall XR, Dexedrine, Metadate CD, Ritalin
More informationPequot Health Care Opioid Analgesic Quantity Program*
Pequot Health Care 1 Annie George Drive Mashantucket, CT 06338 Phone: 1-888-779-6638 Fax: 1-860-396-6494 Pequot Health Care Opioid Analgesic Quantity Program* Effective January 2018 *Quantity Program limits
More informationPHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017
PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017 A meeting of the Health Partners Pharmacy and Therapeutics (P&T) Committee was held on September and December 2017. The following are the recommendations
More informationPRESCRIPTION DRUG BENEFITS. open/closed formulary. Capital BlueCross is an Independent Licensee of the BlueCross BlueShield Association
GUIDE TO PRESCRIPTION DRUG BENEFITS open/closed formulary Capital BlueCross is an Independent Licensee of the BlueCross BlueShield Association TABLE OF CONTENTS 2 Contact Us Phone Number Website 3 Using
More informationFuture Formulary Changes
Future Formulary Changes Upd 11/21/2018 Applies to: Employer group plan 2018 2019 open formularies KEY: PA=prior authorization; ST=step therapy; QL=quantity limit Generic name Brand name Change Effective
More informationACITRETIN. Products Affected
ACITRETIN acitretin Other For prophylaxis of skin cancer in patients with previously treated skin cancers who have undergone an organ transplantation the request will be approved. For psoriasis: the patient
More informationPrescription Guidelines Exchange (Effective January 2019)
Prescription Guidelines Exchange (Effective January 2019) Some medications are only intended to be used in limited quantities, others require advanced approval or prior authorization by your doctor before
More informationACAMPROSATE (CAMPRAL)
ACAMPROSATE (CAMPRAL) ACAMPROSATE CALCIUM Creatinine clearance less than 30 PAGE 1 LAST UPDATED 06/2016 ADALIMUMAB (HUMIRA) HUMIRA, HUMIRA PEDIATRIC CROHN'S, HUMIRA PEN, HUMIRA PEN CROHN'S-UC-HS, HUMIRA
More informationPharmacy and Medical Guideline Updates
STAT Bulletin PO Box 15013 Albany, New York 12212 August 2, 2010 Volume 8: Issue 19 To: All PCPs and Specialists Contracts Affected: All Lines of Business Pharmacy and ical Guideline Updates As a result
More informationDepartment of Origin: Integrated Healthcare Services. Approved by: Chief Medical Officer Department(s) Affected: Date approved: 01/10/17
Reference #: MP/D005 Page: 1 of 3 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan
More informationReason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
More informationRAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)
INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193
More informationPrior Authorization Opioid Overutilization 2017
Drugs Requiring Prior Authorization Label Name ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE CAPSULE ACETAMINOPHEN/CODEINE SOLUTION ACETAMINOPHEN/CODEINE TABLET ASCOMP/CODEINE CAPSULE BUTALBITAL/CAFFEINE/ACETAMINOPHEN/CODEINE
More informationPrior Authorization Drug List
Prior Authorization Drug List This is a list of drugs that require Prior Authorization before coverage is provided. If you are prescribed a medication that requires Prior Authorization, your physician
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select October 1, 2018 Updates Drug Name efavirenz 600mg (Brand = Sustiva ) trientine (Brand = Syprine ) hydrocortisone lot 0.1% (Brand = Locoid ) sumatriptan-naproxen
More informationStep Therapy Criteria
Step Therapy Group ADCIRCA 1772-D ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 Step Therapy Group ANTIPSYCHOTICS
More informationACNE AGENTS_NVT Chinese Community Health Plan Senior Select Program (HMO SNP)
ACNE AGENTS_NVT adapalene topical cream adapalene topical gel Avita tretinoin tretinoin microspheres topical gel Age Other 1 ADAGEN_NVT Adagen Age Other 2 ADCIRCA_NVT 2017 Adcirca Diagnosis confirmed by
More informationSpecialty Overview by Prior Authorization Approval or Denial 4th Quarter 2016
Specialty Overview by Prior Authorization Approval or 4th Quarter 2016 Carrier Physician Specialty Drug Drug Class Decision Comments Reporting Year Reporting Month 3961 GASTROENTEROLOGY Humira RHEUMATOID
More informationFuture Formulary Changes
Future Formulary Changes Applies to: Employer group plan 2019 open formularies with specialty tiers KEY: PA=prior authorization; ST=step therapy; QL=quantity limit Obeticholic acid Ocaliva Limited to Kaiser
More informationPlan Year 2018 Prior Authorization (PA) Criteria
Plan Year 2018 Prior Authorization (PA) Criteria Prior Authorization: Commonwealth Care Alliance requires you (or your physician) to get prior authorization for certain drugs. This means that you will
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Self Administered Oncology Agents Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Self Administered Oncology Agents Prime Therapeutics will review Prior
More informationDrug Bill As Unit Common Directions Common Day Supply Common Billing Errors Oral Tablets/Capsules
Note: This is a guide for commonly misbilled medications. Please submit the claims according to directions for use indicated on the prescription order. Drug Bill As Unit Common Directions Common Day Supply
More informationACNE AGENTS_NVT Chinese Community Health Plan Senior Select Program (HMO SNP)
ACNE AGENTS_NVT adapalene 0.3% gel pump adapalene topical cream adapalene topical gel avita tretinoin tretinoin microspheres topical gel Age Other 1 ADAGEN_NVT ADAGEN Age Other 2 ADCIRCA_NVT 2017 ADCIRCA
More information2010 Drugs Requiring Prior Authorization
2010 Drugs Requiring Prior Authorization Drugs Covered Uses Exclusion Criteria Actemra (tocilizumab) Adcirca (tadalafil) Alfa Interferons - Alferon N - Infergen - PEG-Intron - PEG-Intron Redipen - Pegasys
More informationABRAXANE. Products Affected. Prior Authorization Criteria 2019 Secure-Extra PDP 6 Tier Last Updated: 12/2018. Abraxane
Prior Authorization 2019 Secure-Extra PDP 6 Tier Last Updated: 12/2018 ABRAXANE Abraxane PA Details Age Other B vs D coverage determination 1 ACITRETIN Acitretin PA Details Documentation of diagnosis.
More informationProducts Affected ACTEMRA SUBCUTANEOUS ACTEMRA INTRAVENOUS SOLUTION 400 MG/20 ML (20 MG/ML), 80 MG/4 ML (20 MG/ML)
Current as of October 1, 2016 ACTEMRA ACTEMRA SUBCUTANEOUS ACTEMRA INTRAVENOUS SOLUTION 400 MG/20 ML (20 MG/ML), 80 MG/4 ML (20 MG/ML) PA Other Documentation of diagnosis, previous treatment with one or
More informationANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017
ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE
More informationQuantity Management. April 2018
Quantity Management April 2018 What Is Quantity Management? It s a quality and safety program that promotes the safe use of medications. The program limits the amount of some medications we cover. We base
More informationPrior Authorization Approval Guidelines. May, 2017
Prior Authorization Approval Guidelines May, 2017 Prior Authorization Approval Guidelines Please be advised that in order to be considered for approval, all applicable prior therapies must be listed on
More informationMedicaid Managed Care Prior Authorization List
Allergen Extracts Alzheimer's Angioedema Anthelmintics Trade Name: GRASTEK, ORALAIR, RAGWITEK Trade Name: NAMZARIC Trade Name: BERINERT, CINRYZE, FIRAZYR, RUCONEST Trade Name: EMVERM Attention Deficit
More informationSpecialty Overview by Prior Authorization Approval or Denial 2nd Quarter 2016
Specialty Overview by Prior Authorization Approval or 2nd Quarter 2016 3961 DERMATOLOGY Humira RHEUMATOID ARTHRITIS Approval Approved from 04/13/2016 thru 04/13/2018 3961 DERMATOLOGY Stelara PSORIASIS
More informationAAT DEFICIENCY. Products Affected Aralast Np INJ 1000MG, 500MG Glassia Prolastin-c INJ 1000MG Zemaira
AAT DEFICIENCY Aralast Np INJ 1000MG, 500MG Glassia Prolastin-c INJ 1000MG Zemaira PA Details Other Diagnosis of severe congenital A1-PI deficiency who have clinically evident emphysema, weight, A1-PI
More informationACTEMRA. Products Affected ACTEMRA. Covered Uses All FDA-approved indications not otherwise excluded from Part D. N/A. Exclusion Criteria
ACTEMRA ACTEMRA New starts: Patient has a diagnosis of moderate to severe rheumatoid arthritis (IV or subcutaneous dosage form) and has had a failure, contraindication, or intolerance to two of the following:
More informationGUIDE TO PRESCRIPTION DRUG BENEFITS SELECTIVELY CLOSED FORMULARY. Capital BlueCross is an Independent Licensee of the BlueCross BlueShield Association
GUIDE TO PRESCRIPTION DRUG BENEFITS SELECTIVELY CLOSED FORMULARY Capital BlueCross is an Independent Licensee of the BlueCross BlueShield Association TABLE OF CONTENTS 3 Contact Information Customer Service
More information01/10/17. Replaces Effective Policy Dated: Amino Acid Based Elemental Formula (AABF) 09/28/15 Reference #: MP/A003 Page: 1 of 3
Reference #: MP/A003 Page: 1 of 3 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan
More informationSPECIALTY PHARMACY Master Clinical Drug List
Abraxane J9264 Provider ONCOLOGY None NO Actemra J3262 Provider ARTHRITIS PA - all YES Acthar HP Gel J0800 Prov/Self Med/Pharm ENDOCRINE/METABOLIC PA - all YES Adagen J2504 Provider ENZYME DISORDERS None
More informationOptumRx Focused Utilization Management Program
Utilization management updates - January 1, 2019 OptumRx Focused Utilization Management Program OptumRx focused step therapy with quantity limits programs If you have a prescription for any of the Step
More informationDrugs Requiring Prior Authorization When certain medications require prior authorization
Drugs Requiring Prior Authorization When certain medications require prior authorization Express Scripts is required to review prescriptions for certain medications with your doctor before they can be
More informationCentral Nervous System Stimulants Drug Class Prior Authorization Protocol
Line of Business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Central Nervous System Stimulants Drug Class Prior Authorization Protocol This policy has been developed through
More information